<DOC>
	<DOCNO>NCT00227318</DOCNO>
	<brief_summary>The purpose study determine effectiveness candesartan cilexetil prevent hypertension people high normal blood pressure . Patients randomize either Candesartan placebo initial 2-year period follow second 2-year period placebo patient .</brief_summary>
	<brief_title>TROPHY - Candesartan Cilexetil Long-term Hypertension Prevention Trial</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Candesartan</mesh_term>
	<mesh_term>Candesartan cilexetil</mesh_term>
	<criteria>Subjects age 30 65 ( inclusive ) time informed consent process average clinic BP high normal range &lt; 139/8589 mmHg 130139/ &lt; 89 mm Hg ( high normal BP range ) ( mean systolic and/or diastolic pressure base 3 consecutive measurement ) derive average clinic visit 1,2 3 . Have proteinuria &gt; 1 + ( dipstick method ) stroke , myocardial infarction ( MI ) , transient ischemic attack ( TIA ) , presence clinically significant evidence atherosclerosis hypertensive target organ involvement significant medical condition may compromise participation study .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2011</verification_date>
</DOC>